Skin Fluorescent Imaging Shows High Sensitivity, Specificity for Discriminating Melanoma Lesions
-
By
-
April 6, 2026
-
2 min
-
1
Skin fluorescent imaging offers an effective noninvasive approach to melanoma diagnosis.
-
2
The phase II trial assessed 240 suspicious lesions across the U.S.
-
3
Sensitivity was 93% and specificity was 77% at cutoff score
-
4
41% of lesions were benign with no dysplasia.
-
5
High-grade dysplasia was present in 21% of lesions.
-
6
Led by Dr. Douglas Grossman, the trial aims to reduce unnecessary biopsies.
-
7
The method targets αvβ3 integrin in the tumor microenvironment.